Sophia Genetics (SOPH) Fundamental Analysis: Revenue, Earnings & Valuation

9.84 / 10

Outperform

Fundamental analysis rates SOPH as Outperform with a 9.8/10 positioning. Revenue‑MV and Cash‑UP are bullish, while Profit‑MV and Net‑income‑Revenue lag. The composite fund score is 9.84, driven by strong Asset‑MV and Revenue‑MV factors, indicating robust valuation despite profit gaps.

Analysis Checks(3/10)

Revenue-MV

Value-0.90

Score3/3

Weight163.31%

1M Return3.85%

Net cash flow from operating activities / Operating revenue (%)

Value-46.45

Score1/3

Weight-9.42%

1M Return-0.28%

Profit-MV

Value0.66

Score1/3

Weight-98.22%

1M Return-2.85%

Net income-Revenue

Value-0.04

Score1/3

Weight-87.92%

1M Return-2.58%

Net profit margin (%)

Value-102.24

Score1/3

Weight7.97%

1M Return0.24%

Cash-UP

Value-0.15

Score3/3

Weight103.22%

1M Return2.45%

Net cash flow from operating activities / Total liabilities (%)

Value-0.31

Score1/3

Weight-129.12%

1M Return-4.08%

EBIT / Total operating revenue (%)

Value-96.81

Score1/3

Weight-19.17%

1M Return-0.58%

Asset-MV

Value-0.55

Score3/3

Weight161.38%

1M Return3.88%

Net profit / Total operating revenue (%)

Value-102.24

Score1/3

Weight7.97%

1M Return0.24%

Is SOPH fundamentally strong?

SOPH scores 9.84/10 on fundamentals and holds a Discounted valuation at present. Backed by its -110.00% ROE, -102.24% net margin, -4.57 P/E ratio, 7.66 P/B ratio, and -23.16% earnings growth, these metrics solidify its Outperform investment rating.